EMEA-000468-PIP02-12-M05

Key facts

Invented name
Noxafil
Active substance
posaconazole
Therapeutic area
Infectious diseases
Decision number
P/0223/2019
PIP number
EMEA-000468-PIP02-12-M05
Pharmaceutical form(s)
  • Oral suspension
  • Gastro-resistant tablet
  • Powder for oral suspension / modified-release granules for oral suspension
  • Concentrate for solution for infusion
Condition(s) / indication(s)
  • Prevention of invasive fungal infections
  • Treatment of invasive fungal infections
Route(s) of administration
  • Oral use
  • Intravenous use
Contact for public enquiries
Merck Sharp & Dohme (Europe), Inc.
Tel. +33 180464738
E-mail: pip.information@merck.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
1 rating